USA Financial Formulas’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-243
| Closed | -$33.5K | – | 340 |
|
|
2024
Q2 | $33.5K | Sell |
243
-87
| -26% | -$12K | 0.01% | 243 |
|
|
2024
Q1 | $45.5K | Buy |
+330
| New | +$45.5K | 0.01% | 243 |
|
|
2023
Q2 | – | Sell |
-5
| Closed | -$506 | – | 500 |
|
|
2023
Q1 | $506 | Buy |
+5
| New | +$506 | ﹤0.01% | 363 |
|
|
2018
Q1 | – | Sell |
-6,511
| Closed | -$505K | – | 376 |
|
|
2017
Q4 | $505K | Buy |
+6,511
| New | +$505K | 0.12% | 142 |
|